MedLite ID - Now available in the United States, European Union, and Middle East – the innovative, simple, and disposable device eliminates IV drug line-tracing errors.
October 8, 2024 – Orion Innovations, a healthcare technology platform company, announced the expansion of its innovative product, MedLite ID, into its third major market worldwide. The eight-time patented MedLite ID Smart-Lite system, identifies and illuminates the Keep Vein Open (KVO) infusion line in seconds, helping prevent hospital infusion line-tracing errors known as Adverse Drug Events (ADEs). Available in the United States, and now adding major markets in the European Union as well as the Middle East, MedLite ID is poised to significantly improve the levels of patient safety and risk reduction in hospitals worldwide.
“With an average of eight IV lines per patient in the ICU, IVs and line-tracing prior to injection are some of the highest volume procedures in the hospital. Correspondingly, the risk for ‘infusion confusion’ is high in today’s acute care settings since current methods, including tape and labels used for line identification, lack standardization, are time-intensive to apply, and are plagued by handwriting and poor adherence issues. Workforce-related challenges, including nurse shortages, traveling nurses, and darkened rooms, have only increased risk,” said Rodney Schutt, President & CEO of Orion Innovations. “By investing in our simple, yet innovative, MedLite ID solution, hospitals around the world are creating a safer, simpler means to choose the right line, which reduces errors and brings down direct costs as well as hospital liability risk.”
The scale of the issue is alarming: 56 percent of all ADEs are infusion-related and 26 percent are life-threatening with 15 percent of infusion ADE being "wrong route errors” whereby the correct drug is injected into the wrong line. With more patients and fewer nurses, compounded by the 19 percent nurse attrition in 2021 following covid-19, line-tracing needs to be faster and more effective. With 60-90 percent of all IV infusions in the United States containing one or more errors, healthcare providers are paying an average of $2,200 in avoidable ADE costs per day per 100 beds in the hospital. That does not count upwards of $5++ million in estimated wrongful-death legal costs should such an error occur, and the average settled cost of an ADE is $240,000.
By making the Keep Vein Open (KVO) line instantly identifiable, even in dark environments, patients with multiple IVs remain safe throughout the interdepartmental journey. Often described as powerfully simple as the “seatbelt” – MedLite ID prevents drug-to-drug head-on collisions. Attaching to any currently used IV line within the hospital, and disposable without change to workflow, it provides a standardized solution with attachment in less than 60 seconds.
Commenting on Intensive Care units, where up to seventeen intermittent meds are given daily, Bruce Cusson, a former Registered Nurse with Wake Forest School of Medicine, said: “In an acute-care setting, there may be easily 6-8 powerful meds (vasoactive drips and sedatives) that an IV push medication given in the wrong line could prove fatal. Clearly identifying the ‘carrier’ would be easy with the clip-on-line device. You try tracing 8 all-look-alike lines and trace the patient’s port and see how easy it is.”
MedLite ID was invented by Dr. Wayne Provost, Chairman of the Board for Orion Innovations, who lost his son, Dusty, to cancer and observed that he was connected to over 11 IV lines during his treatment and witnessed first-hand the potential for a life-ending infusion error. For individual hospitals, adopting MedLite ID gives peace of mind in knowing that ADEs are virtually eliminated, preventing any accidental deaths, and related lawsuits. Growing liability settlements and labor shortages due to COVID-19 have led to a more cautious and hesitant standard of care, something MedLite ID seeks to address. Hospitals’ nurses are less stressed with hospitalwide standardization achieved in less than one day of deployment. Trusted by acute facilities, VA/DoD, and air ambulance services around the globe, MedLite ID continues to assert itself as a cutting-edge solution in patient safety.
Media Contact:
Travis Small
617.538.9041 (cell)
Orion Innovations is advancing new and disruptive technologies that improve patient safety for the highest quality outcomes. Grounded in the principle that robust solutions can be simple to adopt, the healthcare technology platform company is focused on incubating and commercializing new products that enable caregivers and facilities to implement the best possible patient experience while improving the overall bottom line.
The company’s portfolio includes the MedLite ID Smart-Lite solution for the acute healthcare market to prevent infusion Adverse Drug Events, NoGag as a solution to dental procedures and patients impacted by the gag reflex, and OxySwitch as an oxygen switching device for the hospital reducing TimeWithout-O2. All smart, simple, and patented.
To learn more, visit https://www.orioninnovationsgroup.com